[N-(gamma-(4-phenoxymethylphenyl)propyl)-morpholine--a new surface anesthetic of remarkable tolerance. 6. Report on the syntheses of new compounds with local anethetic effect. 1].
D000779:Anesthetics, Local / Q000008:administration & dosage / Q000138:chemical synthesis / Q000633:toxicity; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003315:Cornea / Q000187:drug effects; D004285:Dogs; D004342:Drug Hypersensitivity; D004361:Drug Tolerance; D005658:Fungi / Q000187:drug effects; D006168:Guinea Pigs; D006801:Humans; D008012:Lidocaine / Q000633:toxicity; D051379:Mice; D009025:Morpholines / Q000138:chemical synthesis / Q000633:toxicity; D009132:Muscles / Q000494:pharmacology; D011343:Procaine / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D013748:Tetracaine / Q000633:toxicity
D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D009025:Morpholines; D013748:Tetracaine; D011343:Procaine; D008012:Lidocaine
N-(gamma-(4-Phenoxymethyl-phenyl)-propyl)-morpholin--ein neues Oberflächenanästheticum von bemerkenswerter Verträglichkeit. 6. Mitteilung über Synthesen neuer Verbindungen mit lokalanästhetischer Wirkung, 1.